Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a recruitment notice 'No longer looking for participants' and new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Updated the revision tag from v3.5.5 to v3.6.0 and changed the heading 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.5%
    Check dated 2026-06-12T11:33:29.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag (v3.5.5) replacing the previous v3.5.4, indicating an update to the page template or underlying system.
    Difference
    0.1%
    Check dated 2026-06-05T08:40:32.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4. This indicates a minor version update to the page rendering/content management, with no substantive changes to study data or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-15T05:25:48.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software release rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:28.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:37.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.